•  
  •  
  •  
  •  

2025-10-19 10:06:06

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Emirates NBD to acquire majority stake in RBL Bank through primary infusion of ~USD 3bn
  • PNGS Gargi Fashion Jewellery Ltd opens new store at Pajifond, Margao
  • Satchmo Holdings Ltd discharges its total liability as per OTS
  • Zenith Steel Pipes & Industries Ltd inks MoU with Lloyds Realty Developers Ltd to develop its land
  • Sejal Glass Ltd consolidated Q2 FY26 net profit rises to Rs. 8.02 crores

Keywords Selected:  MA

Research

  • Croma's Unboxed 2022 decodes key consumer shopping trends!
  • Anand Rathi Report: India Pharma - Healthy growth in Dec'22; volumes slow down
  • New global research from Mastercard reveals Indian consumers' payment preferences
  • Expanded distillery capabilities and better realisations will increase integrated sugar mills' performance this fiscal: ICRA
  • Quant Thematic - Three factor model for stocks filtration
  • Aurobindo Pharma - Entry into India - a little too late?
  • Natco Pharma - Natco and Teva launch Revlimid in the US - ICICI Securities

Market Commentary

  • Nifty slipped below its 100-DMA amid broad-based selling led by Technologies names - Swastika Investmart Ltd

Stock Report

  • NATCO Pharma Limited - Legal update regarding Risdiplam
  • PVR INOX launches new all-laser cinema in Siliguri at ML Acropolis Mall
  • Relonchem Limited receives Marketing Authorization for two of its products
  • Legal update regarding Risdiplam - Commercial Appellate Division of the Hon'ble Delhi High Court Dismissed Appeal
  • PVR INOX Ltd opens India's First-Ever Luxury Dine-In Cinema at M5 ECity Mall in Bengaluru
  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
  • Wockhardt Submits New Drug Application to U.S. FDA for Zidebactam-Cefepime for Treatment of Serious GramNegative Infections
  • Lupin Strengthens its Global Specialty Ophthalmology Business with acquisition of VISUfarma from GHO Capital
  • Glenmark Strengthens Oncology Portfolio with Hengrui's HER2 Targeting ADC For Multiple Regions
  • Lemon Tree Hotels signs two new properties, one each in Uttar Pradesh and Madhya Pradesh
  • Relonchem Limited receives Marketing Authorization for its products
  • Shelter Pharma's Participation in AYUSH India Expo 2025
  • Shilpa Medicare Ltd receives initial authorization for Rivaroxaban Orodispersible Films from Europe
  • Shelter Pharma Ltd installs 15 KW solar power plant
  • Fire Incident at APL Healthcare Ltd's Unit 4 at Naidupeta
  • CuraTeQ Biologics Pvt Ltd completes Phase 3 Clinical Study for Denosumab Biosimilar
  • NLC India Ltd awarded IPMA Delta Certification - Level 3
  • NATCO Pharma Ltd updates on acquisition of Adcock Ingram
  • Apitoria Pharma Pvt Ltd receives 5 observations from USFDA for API facility
  • Gland Pharma receives approval for Vasopressin in 5% Dextrose RTU Injection
  • CuraTeQ Biologics receives approval for biosimilar Dazublys from UK's MHRA
  • Shelter Pharma Ltd receives new order
  • Crisil ESG Ratings & Analytics Ltd assigns Crisil ESG 57 rating to Mankind Pharma Limited
  • Piramal Pharma Solutions and NewAmsterdam Pharma announce dedicated OSD production Capabilities at Piramal's Sellersville, Pennsylvania Site

Industry News

  • Aviva India launches Aviva Nivesh Bima

Latest Post

  • Emirates NBD to acquire majority stake in RBL Bank through primary infusion of ~USD 3bn
  • PNGS Gargi Fashion Jewellery Ltd opens new store at Pajifond, Margao
  • Satchmo Holdings Ltd discharges its total liability as per OTS
  • Zenith Steel Pipes & Industries Ltd inks MoU with Lloyds Realty Developers Ltd to develop its land
  • Sejal Glass Ltd consolidated Q2 FY26 net profit rises to Rs. 8.02 crores


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024